Literature DB >> 34724195

Total opioid-free general anaesthesia can improve postoperative outcomes after surgery, without evidence of adverse effects on patient safety and pain management: A systematic review and meta-analysis.

Alexander Olausson1, Carl Johan Svensson2,3, Paulin Andréll3,4, Pether Jildenstål1,5,6,7, Sven-Egron Thörn2,3, Axel Wolf1,2,8.   

Abstract

BACKGROUND: Opioid-based treatment is used to manage stress responses during surgery and postoperative pain. However, opioids have both acute and long-term side effects, calling for opioid-free anaesthetic strategies. This meta-analysis compares adverse events, postoperative recovery, discharge time from post-anaesthesia care unit, and postoperative pain, nausea, vomiting, and opioid consumption between strict opioid-free and opioid-based general anaesthesia.
METHODS: We conducted a systematic review and meta-analysis. We searched PubMed, Embase, Cinahl, Cochrane Library, selected reference lists, and Google Scholar. We included randomised controlled trials (RCTs) published between January 2000 and February 2021 with at least one opioid-free study arm, i.e. no opioids administered preoperatively, during anaesthesia induction, before skin closure, or before emergence from anaesthesia.
RESULTS: The study comprised 1934 patients from 26 RCTs. Common interventions included laparoscopic gynaecological surgery, upper gastrointestinal surgery, and breast surgery. There is firm evidence that opioid-free anaesthesia significantly reduced adverse postoperative events (OR 0.32, 95% CI 0.22 to 0.46, I2  = 56%, p < 0.00001), mainly driven by decreased nausea (OR 0.27, (0.17 to 0.42), p < 0.00001) and vomiting (OR 0.22 (0.11 to 0.41), p < 0.00001). Postoperative opioid consumption was significantly lower in the opioid-free group (-6.00 mg (-8.52 to -3.48), p < 0.00001). There was no significant difference in length of post-anaesthesia care unit stay and overall postoperative pain between groups.
CONCLUSIONS: Opioid-free anaesthesia can improve postoperative outcomes in several surgical settings without evidence of adverse effects on patient safety and pain management. There is a need for more evidence-based non-opioid anaesthetic protocols for different types of surgery as well as postoperative phases.
© 2021 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Keywords:  OFA; adverse events; opioid consumption; opioid-free anaesthesia; postoperative nausea and vomiting; postoperative pain; recovery

Mesh:

Substances:

Year:  2021        PMID: 34724195     DOI: 10.1111/aas.13994

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

Review 1.  Impact of Opioid-Free Anesthesia on Analgesia and Recovery Following Bariatric Surgery: a Meta-Analysis of Randomized Controlled Studies.

Authors:  I-Wen Chen; Cheuk-Kwan Sun; Kuo-Chuan Hung; Chong-Chi Chiu; Chih-Wei Hsu; Chien-Ming Lin; Shu-Wei Liao; I-Chia Teng
Journal:  Obes Surg       Date:  2022-07-19       Impact factor: 3.479

2.  The Effect of Opioid-Free Anesthesia on the Quality of Recovery After Gynecological Laparoscopy: A Prospective Randomized Controlled Trial.

Authors:  Hoon Choi; Jae Yen Song; Eun Jee Oh; Min Suk Chae; Sanghyuck Yu; Young Eun Moon
Journal:  J Pain Res       Date:  2022-08-03       Impact factor: 2.832

3.  Analgesic and Anesthetic Efficacy of Rocuronium/Sugammadex in Otorhinolaryngologic Surgery: A Propensity Score-Matched Analysis.

Authors:  En-Bo Wu; Chao-Ting Hung; Sheng-Dean Luo; Shao-Chun Wu; Tsung-Yang Lee; Jo-Chi Chin; Peng-Neng Tsai; Johnson Chia-Shen Yang
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19

4.  Ultrasound-guided paravertebral blockade reduced perioperative opioids requirement in pancreatic resection: A randomized controlled trial.

Authors:  Ye Han; Yuanqiang Dai; Yaping Shi; Xiaoxiu Zhang; Boyang Xia; Qiufang Ji; Xiya Yu; Jinjun Bian; Tao Xu
Journal:  Front Surg       Date:  2022-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.